104 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... for the Management ... #HeartFailure #Management ... #CHF #guideline ... ACCAHA2017 #cardiology #treatment
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Rheumatoid Arthritis - ACR ... 2021 Guidelines ... Tapering DMARDs - Treatment ... Arthritis #ACR2021 #Guidelines ... #management #treatment
Acute Treatment of Migraine

- BWH Medicine Chiefs @BrighamChiefs

#Migraine #Treatment #management #neurology #headache #medications
Acute Treatment ... #Migraine #Treatment ... #management #neurology ... #headache #medications
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... - ACR/VF 2021 Guidelines ... for Treatment & ... #Treatment #ACR2021 ... #Guidelines #algorithm
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... functional ID) Guidelines ... : • ACC/AHA 2017 ... heartfailure #diagnosis #management ... #guidelines
Algorithm for the Treatment of Parkinson Disease With Predominant Postural Instability and Gait Impairment

#Management #Neurology #Parkinsons
Algorithm for the Treatment ... Impairment #Management ... #Neurology #Parkinsons ... #Disease #Medication ... #Treatment #Initiation
Medications Used in Hypertensive Emergencies
Vasodilators: Hydralazine, Nitroglycerin, Sodium nitroprusside 
Calcium Channel Blockers: Clevidipine, Nicardipine
ß-Blockers: Esmolol, Labetalol,
Medications Used ... Labetalol, Metoprolol ACE ... #Hypertension #Medications ... #Management #Treatment
Scabies (Sarcoptes scabiei) - CDC 2021 Treatment Guidelines
Recommended Regimen:
 • permethrin 5% cream applied to all
scabiei) - CDC 2021 Treatment ... Guidelines Recommended ... cream applied to all ... lotion applied to all ... #Guidelines #Management
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... increase to 500 mcg ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... the use of this medication
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... for the Management ... with ‘treatment ... for inclusion all ... Personality #Disorder #Medications